This clinical trial is testing whether a daily pill called Xanamem can help control symptoms in people with mild to moderate Alzheimer's disease dementia. The study involves 247 participants who will take either the medication or a placebo for 36 weeks, followed by an optional ex…
Phase: PHASE2, PHASE3 • Sponsor: Actinogen Medical • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC